Sun Pharmaceutical says it won’t expand US manufacturing base amid tariff concerns
[ad_1] India’s largest drug maker Sun Pharmaceutical has no plans to further expand its manufacturing base in the US even as potential reciprocal tariff remains a significant unknown that could disrupt the sector that operates on thin margins. “We have a significant footprint in the United States and at this time we have no plans…